338 related articles for article (PubMed ID: 32215172)
1. Therapeutic Potential of Diosgenin and Its Major Derivatives against Neurological Diseases: Recent Advances.
Cai B; Zhang Y; Wang Z; Xu D; Jia Y; Guan Y; Liao A; Liu G; Chun C; Li J
Oxid Med Cell Longev; 2020; 2020():3153082. PubMed ID: 32215172
[TBL] [Abstract][Full Text] [Related]
2. Diosgenin: An Updated Pharmacological Review and Therapeutic Perspectives.
Semwal P; Painuli S; Abu-Izneid T; Rauf A; Sharma A; Daştan SD; Kumar M; Alshehri MM; Taheri Y; Das R; Mitra S; Emran TB; Sharifi-Rad J; Calina D; Cho WC
Oxid Med Cell Longev; 2022; 2022():1035441. PubMed ID: 35677108
[TBL] [Abstract][Full Text] [Related]
3. Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases.
Parama D; Boruah M; Yachna K; Rana V; Banik K; Harsha C; Thakur KK; Dutta U; Arya A; Mao X; Ahn KS; Kunnumakkara AB
Life Sci; 2020 Nov; 260():118182. PubMed ID: 32781063
[TBL] [Abstract][Full Text] [Related]
4. Anticancer Activity of Diosgenin and Its Molecular Mechanism.
Ren QL; Wang Q; Zhang XQ; Wang M; Hu H; Tang JJ; Yang XT; Ran YH; Liu HH; Song ZX; Liu JG; Li XL
Chin J Integr Med; 2023 Aug; 29(8):738-749. PubMed ID: 36940072
[TBL] [Abstract][Full Text] [Related]
5. UPLC-QTOF-MS identification of metabolites in rat biosamples after oral administration of Dioscorea saponins: a comparative study.
Tang YN; Pang YX; He XC; Zhang YZ; Zhang JY; Zhao ZZ; Yi T; Chen HB
J Ethnopharmacol; 2015 May; 165():127-40. PubMed ID: 25698242
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review.
Sun F; Yang X; Ma C; Zhang S; Yu L; Lu H; Yin G; Liang P; Feng Y; Zhang F
Diabetes Metab Syndr Obes; 2021; 14():4015-4030. PubMed ID: 34552341
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential and research progress of diosgenin for lipid metabolism diseases.
Zhang SZ; Liang PP; Feng YN; Yin GL; Sun FC; Ma CQ; Zhang FX
Drug Dev Res; 2022 Dec; 83(8):1725-1738. PubMed ID: 36126194
[TBL] [Abstract][Full Text] [Related]
8. Targeting endoplasmic reticulum stress using natural products in neurological disorders.
Jangra A; Verma M; Kumar D; Chandrika ; Rachamalla M; Dey A; Dua K; Jha SK; Ojha S; Alexiou A; Kumar D; Jha NK
Neurosci Biobehav Rev; 2022 Oct; 141():104818. PubMed ID: 35940309
[TBL] [Abstract][Full Text] [Related]
9. Diosgenin: Recent Highlights on Pharmacology and Analytical Methodology.
Jesus M; Martins AP; Gallardo E; Silvestre S
J Anal Methods Chem; 2016; 2016():4156293. PubMed ID: 28116217
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Biological Evaluation of Diosgenin-Amino Acid Derivatives with Dual Functions of Neuroprotection and Angiogenesis.
Cai D; Qi J; Yang Y; Zhang W; Zhou F; Jia X; Guo W; Huang X; Gao F; Chen H; Li T; Li G; Wang P; Zhang Y; Lei H
Molecules; 2019 Nov; 24(22):. PubMed ID: 31703284
[TBL] [Abstract][Full Text] [Related]
11. Prevention properties on cerebral ischemia reperfusion of medicine food homologous Dioscorea yam-derived diosgenin based on mediation of potential targets.
Zhang X; Wang X; Xue Z; Zhan G; Ito Y; Guo Z
Food Chem; 2021 May; 345():128672. PubMed ID: 33352403
[TBL] [Abstract][Full Text] [Related]
12. Water-Soluble Arginyl-Diosgenin Analog Attenuates Hippocampal Neurogenesis Impairment Through Blocking Microglial Activation Underlying NF-κB and JNK MAPK Signaling in Adult Mice Challenged by LPS.
Cai B; Seong KJ; Bae SW; Kook MS; Chun C; Lee JH; Choi WS; Jung JY; Kim WJ
Mol Neurobiol; 2019 Sep; 56(9):6218-6238. PubMed ID: 30740619
[TBL] [Abstract][Full Text] [Related]
13. Carvacrol as a Potential Neuroprotective Agent for Neurological Diseases: A Systematic Review Article.
Zamanian MY; Kujawska M; Nikbakhtzadeh M; Hassanshahi A; Ramezanpour S; Kamiab Z; Bazmandegan G
CNS Neurol Disord Drug Targets; 2021; 20(10):942-953. PubMed ID: 33970850
[TBL] [Abstract][Full Text] [Related]
14. Pro-Apoptotic and Anti-Cancer Properties of Diosgenin: A Comprehensive and Critical Review.
Sethi G; Shanmugam MK; Warrier S; Merarchi M; Arfuso F; Kumar AP; Bishayee A
Nutrients; 2018 May; 10(5):. PubMed ID: 29783752
[TBL] [Abstract][Full Text] [Related]
15. A review on therapeutic potentials of Trigonella foenum graecum (fenugreek) and its chemical constituents in neurological disorders: Complementary roles to its hypolipidemic, hypoglycemic, and antioxidant potential.
Zameer S; Najmi AK; Vohora D; Akhtar M
Nutr Neurosci; 2018 Oct; 21(8):539-545. PubMed ID: 28504078
[TBL] [Abstract][Full Text] [Related]
16. Dioscin and diosgenin: Insights into their potential protective effects in cardiac diseases.
Li X; Liu S; Qu L; Chen Y; Yuan C; Qin A; Liang J; Huang Q; Jiang M; Zou W
J Ethnopharmacol; 2021 Jun; 274():114018. PubMed ID: 33716083
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV Supplementation Promotes A Neuroprotective Effect in Experimental Models of Neurological Disorders: A Systematic Review.
Costa IM; Lima FOV; Fernandes LCB; Norrara B; Neta FI; Alves RD; Cavalcanti JRLP; Lucena EES; Cavalcante JS; Rego ACM; Filho IA; Queiroz DB; Freire MAM; Guzen FP
Curr Neuropharmacol; 2019; 17(7):648-665. PubMed ID: 30207235
[TBL] [Abstract][Full Text] [Related]
18. Diosgenin Glucoside Protects against Spinal Cord Injury by Regulating Autophagy and Alleviating Apoptosis.
Chen XB; Wang ZL; Yang QY; Zhao FY; Qin XL; Tang XE; Du JL; Chen ZH; Zhang K; Huang FJ
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30072674
[TBL] [Abstract][Full Text] [Related]
19. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
[TBL] [Abstract][Full Text] [Related]
20. Diosgenin as a Novel Alternative Therapy for Inhibition of Growth, Invasion, and Angiogenesis Abilities of Different Glioblastoma Cell Lines.
Khathayer F; Ray SK
Neurochem Res; 2020 Oct; 45(10):2336-2351. PubMed ID: 32683533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
